Protease-activated receptor-4: A novel mechanism of inflammatory pain modulation

British Journal of Pharmacology

Volumn 150, Issue 2, 2007, Pages 176-185

  Asfaha, S ^a   Cenac, N ^a   Houle, S ^a   Altier, C ^b   Papez, M D ^a   Nguyen, C ^a   Steinhoff, M ^c   Chapman, K ^a   Zamponi, G W ^b   Vergnolle, N ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

Analgesia; Cathepsin G; Inflammation; Protease activated receptor 4; Thrombin

Indexed keywords

ALANYLTYROSYLPROLYLGLYCYLLYSYLPHENYLALANINAMIDE; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CARRAGEENAN; POTASSIUM CHLORIDE; PROTEINASE ACTIVATED RECEPTOR 4; SUBSTANCE P; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CALCIUM MOBILIZATION; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; EDEMA; GRANULOCYTE; HYPERALGESIA; IMMUNOFLUORESCENCE; INFLAMMATION; MALE; MECHANICAL STIMULATION; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSORY NERVE CELL; SPINAL GANGLION; THERMAL STIMULATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; HEAT; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NEURONS, AFFERENT; OLIGOPEPTIDES; PAIN; PAIN THRESHOLD; RATS; RATS, WISTAR; RECEPTORS, THROMBIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOUCH;

EID: 33846554731     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706975     Document Type: Article

References (39)

1. Asfaha S, Brussee V, Chapman K, Zochodne DW, Vergnolle N (2002). Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br J Pharmacol 135: 1101-1106.
2. Bar-Shavit R, Wilner GD (1986). Biologic activities of nonenzymatic thrombin: elucidation of a macrophage interactive domain. Semin Thromb Hemost 12: 244-249.
3. Bar-Shavit R, Kahn A, Wilner G, Fenton J (1983). Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science 220: 728-731.
4. Bretschneider E, Kaufmann R, Braun M, Nowak G, Glusa E, Schror K (2001). Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells. Br J Pharmacol 132: 1441-1446.
5. Camerer E, Huang W, Coughlin SR (2000). Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 97: 5255-5260.
6. Cenac N, Vergnolle N (2005). Proteases and protease-activated receptors (PARs): novel signals for pain. Curr Top Med Chem 5: 569-576.
7. Coelho AM, Vergnolle N, Guiard B, Fioramonti J, Bueno L (2002). Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology 122: 1035-1047.
8. Cottrell GS, Amadesi S, Grady EF, Bunnett NW (2004). Trypsin IV: a novel agonist of protease-activated receptors 2 and 4. J Biol Chem. 279: 13532-13539.
9. D'Andrea MR, Sabam MR, Nguyen NB, Andrade-Gordon P, Saban R (2003). Overriding participation of protease activated receptor (PAR)s 1, 2, 3, and 4 in experimental bladder inflammation. Am J Pathol 162: 907-923.
10. de Garavilla L, Vergnolle N, Young SH, Ennes H, Steinhoff M, Ossovskaya VS et al. (2001). Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol 133: 975-987.
11. Demuth DG, Molleman A (2006). Cannabinoid signalling. Life Sci 78: 549-563.
12. Fang M, Kovacs KJ, Fisher LL, Larson AA (2003). Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin. J Physiol 549: 903-917.
13. Faruqi TR, Weiss EJ, Shapiro MJ, Huang W, Coughlin SR (2000). Structure function analysis of protease activated receptor 4 tethered ligand peptides: determinants of specificity and utility in assays of receptor function. J Biol Chem. 275: 19728-19734.
14. Gao CY, Liu SM, Hu HZ, Gao NA, Kim GY, Xia Y et al. (2002). Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine. Gastroenterology 123: 1554-1564.
15. Herbert J, Dupuy E, Laplace M, Zini J, Bar-Shavit R, Tobelem G (1994). Thrombin induces endothelial cell growth via both a proteolytic and non-proteolytic pathway. Biochem J 303: 227-231.
16. Hollenberg MD, Compton SJ (2002). International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 54: 203-217.
17. Hollenberg MD, Saifeddine M, Al Ani B, Gui Y (1999). Proteinase-activated receptor 4 (PAR4): action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2. Can J Physiol Pharmacol 77: 458-464.
18. Hollenberg MD, Saifeddine M, Sandhu S, Houle S, Vergnolle N (2004). Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo. Br J Pharmacol 143: 443-454.
19. Hoogerwerf WA, Hellmich HL, Micci M, Winston JH, Zou L, Pasricha PJ (2002). Molecular cloning of the rat proteinase-activated receptor 4 (PAR4). BMC Mol Biol 3: 2.
20. Houle S, Papez P, Ferazzini M, Hollenberg MD, Vergnolle N (2005). Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation. Br J Pharmacol 146: 670-678.
21. Ishihara H, Connolly A, Zeng D, Kahn M, Zheng Y, Timmons C et al. (1997). Protease-activated receptor-3 is a second thrombin receptor in humans. Nature 386: 502-506.
22. Kahn M, Hammes S, Botka C, Coughlin S (1998a). Gene and locus structure and chromosomal localization of the protease-activated receptor gene family. J Biol Chem 273: 23290-23296.
23. Kahn M, Zheng Y, Huang C, Bigornia V, Zeng D, Moff S et al. (1998b). A dual thrombin receptor system for platelet activation. Nature 394: 690-694.
24. Kataoka H, Hamilton JR, McKemy DD, Camerer E, Zheng YW, Cheng A et al. (2003). Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 102: 3224-3231.
25. Kawabata A, Kuroda R, Kuroki N, Nishikawa H, Kawai K (2000). Dual modulation by thrombin of the motility of rat oesophageal muscularis mucosae via two distinct protease-activated receptors (PARs): a novel role for PAR-4 as opposed to PAR-1. Br J Pharmacol 131: 578-584.
26. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R (2001). Proteinase-activated receptors. Pharmacol Rev 53: 245-282.
27. Mule F, Pizzuti R, Capparelli A, Vergnolle N (2004). Evidence for the presence of functional protease activated receptor 4 (PAR(4)) in the rat colon. Gut 53: 229-234.
28. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR (2000). PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404: 609-613.
29. Nystedt S, Emilsson K, Larsson AK, Strombeck B, Sundelin J (1995). Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem 232: 84-89.
30. Ossovskaya VS, Bunnett NW (2004). Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84: 579-621.
31. Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR (2000). Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 275: 6819-6823.
32. Shapiro MJ, Weiss EJ, Faruqi TR, Coughlin SR (2000). Protease-activated receptors 1 and 4 are shutoff with distinct kinetics after activation by thrombin. J Biol Chem 275: 25216-25221.
33. Steinhoff M, Vergnolle N, Young S et al. (2000). Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6: 151-158.
34. Sutton KG, Martin DJ, Pinnock RD, Lee K, Scott RH (2002). Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. Br J Pharmacol 135: 257-265.
35. Vergnolle N, Bunnett NW, Sharkey KA et al. (2001a). Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 7: 821-826.
36. Vergnolle N, Derian CK, D'Andrea MR, Steinhoff M, Andrade-Gordon P (2002). Characterization of thrombin-induced leukocyte rolling and adherence: a potential pro-inflammatory role for proteinase-activated receptor-4 (PAR-4). J Immunol 169: 1467-1473.
37. Vergnolle N, Wallace JL, Bunnett NW, Hollenberg MD (2001b). Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 22: 146-152.
38. Vu T, Hung D, Wheaton V, Coughlin S (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057-1068.
39. Xu W, Andersen H, Whitmore T, Presnell S, Yee D, Ching A et al. (1998). Cloning and characterization of human protease-activated receptor-4. Proc Natl Acad Sci USA 95: 6642-6646.